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Andrographolide (AND), the diterpene lactone compound, was puriﬁed by HPLC from the methanolic fraction of the plant
Andrographis paniculata. The compound was found to have potent antiplasmodial activity when tested in isolation and in
combination with curcumin and artesunate against the erythrocytic stages of Plasmodium falciparum in vitro and Plasmodium
berghei ANKA in vivo.I C 50s for artesunate (AS), andrographolide (AND), and curcumin (CUR) were found to be 0.05, 9.1
and 17.4μM, respectively. The compound (AND) was found synergistic with curcumin (CUR) and addictively interactive with
artesunate (AS).Invivo,andrographolide-curcuminexhibited better antimalarialactivity, notonlybyreducing parasitemia(29%),
compared to the control (81%), but also by extending the life span by 2-3 folds. Being nontoxicto the in vivo system this agent can
be used as template molecule for designing new derivatives with improved antimalarial properties.
1.Introduction
The discoveries leading to information on novel drugs and
drug combinations have become a priority to manage the
increasing burden of malaria, caused by drug resistant
parasites. Artemisinin derivative-based drug combinations
that have independent mode of action are seen as a way of
enhancing eﬃcacy and simultaneously ensuring protection
against resistance [1, 2] among the parasites. The anti-
malarial properties of a tropical plant Andrographis panic-
ulata has been studied in details recently by Mishra et al.
[3], and also, there are several reports that demonstrate
the antimalarial properties of the plant A. paniculata [4–
6], but there is hardly any report that describe the active
compound responsible for the anti-malarial property of this
plant.Andrographolide,thediterpeniclactonecompound,is
oneofthe major phytoconstituentsoftheplant A. paniculata
and has been reported to have diverse pharmacological
potential including antiviral [7], anti-inﬂammatory [8–11],
and anticancer properties [12]. The present study for the
ﬁrst time establishes andrographolide as the major bioactive
anti-malarial constituent of the plant A. paniculata using
both in vitro and in vivo approaches. The encouraging in
vitro antiplasmodial activities of andrographolide prompted
us to evaluate the interaction of andrographolide (AND)
with other established anti-malarial compounds such as
curcumin (CUR) and artesunate (AS), the hemisuccinate
derivative of artemisinin in vitro on Plasmodium falciparum,
and in vivo on Plasmodium berghei ANKA strains. This adds
new information on combination of potent anti-malarial
compounds for novel combinatorial drug therapy against
drug-resistant malaria.
2.Methods
2.1. Compounds. Pure grade andrographolide, (Sigma-Al-
drich, USA; Cat no. 365645), artesunate (Sigma, USA; Cat2 Journal of Tropical Medicine
no. 3731-100MG) and curcumin (98% Curcuminoid con-
tent, Sigma, USA; Cat no. 7727) were purchased commer-
cially.
2.2. Parasite Strain and In Vitro Culture. Chloroquine-
resistant strain of Plasmodium falciparum (MRC-pf-303)
was obtained from the Malaria Parasite bank, maintained
by the National Institute of Malaria Research, New Delhi.
Parasites were cultured in human O+ washed erythrocytes
using standard protocols [13]. The parasite cultures were
synchronized by treatment with 5% D-Sorbitol [14]. A
tightly synchronized culture was obtained by two sorbitol
treatments that were carried out 12h apart. The residual
schizonts were eliminated by resynchronization, 48h after
the initial synchronization.
2.3. Preparation of Bark Extract. The aerial parts of the plant
A. paniculata were crushed in liquid N2 to ﬁne powder.
Crude extracts were prepared as per the method reported
earlier [3]. Usually, a 0.4% yield of crude extract was ob-
tained invariably from each extraction.
2.4.IsolationofAndrographolidefromtheBarkExtract. Filter-
sterilized crude herbal extracts of A. paniculata were sepa-
rated by HPLC, using C18 column (Agilent Technologies,
1200series)inUVrange(254nm)andat25◦Ctemperatur es.
Fixed ratio of methanol:H2O( 1:1 )w a su s e da st h em o b i l e
phase to sieve the phytoconstituents present in the extracts
at a ﬂow rate of 1mL/min as described by Mishra et al.
[15]. Diﬀerent phytoconstituents that were eluted under
diﬀerent peaks a, b, c, d, and e (Figure 1(a)), were collected
and pooled. The solvent part (methanol) was evaporated
to dryness at 37◦C by the help of a Speed Vac (Model
7811001, Labconco, USA), and the compounds were assayed
individually on Plasmodium falciparum (MRC-pf-303) for
their in vitro antiplasmodial activity.
2.5. In Vitro Antiplasmodial Activity and Drug-Interaction
Tests. Dose-response assays and in vitro drug-interaction
studies were carried out to obtain the 50% inhibitory
concentrations (IC50) and 50% fraction inhibitory con-
centrations (FIC50) of these bioactive compounds, AND,
CUR, and AS, respectively, as described earlier [3, 15].
Corresponding isobolograms (Figures 1(d) and 1(e))w e r e
constructed using the method reported earlier [3, 16].
2.6. In Vivo Toxicity Study. In vivo toxicity study was carried
out using Balb/C mice (20 ± 3g, n = 4). Animals were
injected intraperitoneally with the test compounds aﬀording
doses of 50mg/kg of body weight with one group being
given DMSO (DMSO control) in the same concentration
along with serum-free medium, while the other group of
control was continued without any solvent treatment. Mice
were observed for 96h to record postinjection discomfort,
if any. At the end of 4thday, the gross body weight was
recorded. Animals were bled through heart puncture, and
the blood, and serum were subjected for hematological and
physiological analyses.
2.7. In Vivo Assay of Test Compounds on P. berghei ANKA
Strain. In vivo anti-malarial activity was carried out using 5
groupsofmice(Balb/C,28g ±4g,n = 4).Micewer einjected
intraperitoneally with P. berghei ANKA-infected mouse
blood(approximately40%parasitemia)onday1,atadensity
of 1 × 107 parasites (approximately) of the strain. The test
compounds (AND, AS, CUR, AND+AS, and AND+CUR)
were dissolved in DMSO and serum-free media to make
the desired concentrations and were injected (15mg/kg
of body weight) intraperitoneally to individual groups of
animals starting from 24h prior to the parasite challenge
(day 0). The control mice were maintained simultaneously
without any treatment. Injections were continued daily
till the death of the animals in the control group (13–
15 days). Parasitemia levels (parasitized erythrocytes/total
erythrocytes) were determined with thin blood smears on
every alternate day from day 5 onwards of posttreatment
(Figure 1(f)). The animal experiments complied with all
relevant guidelines and institutional policies on animal
ethicsand wereconductedunderenvironmentally controlled
condition, as reported earlier [3].
3.Results
3.1. Puriﬁcation and Identiﬁcation of Andrographolide. The
phytoconstituents eluted under diﬀerent peaks were assayed
individually in vitro on Plasmodium falciparum.T h ep a r -
ticular phytoconstituent eluted under peak “e” (retention
time 3.78) showed potent anti-malarial activity compared
to the compounds eluted under peaks a, b, c, and d
(Figure 1(a)). The compound of peak “e” was later identiﬁed
as andrographolide by comparing the retention time of
pure andrographolide (Sigma, Cat no. 365645) which was
run as positive control (Figure 1(b))a n dﬁ n a l l yb yu s i n g
standard methods of compound identiﬁcation [15, 17, 18].
Approximately, 50 cycles of HPLC puriﬁcation were carried
out to obtain a suﬃcient amount of test compound, andro-
grapholide (Figure 1(c))f o rt h e i rin vitro anti-plasmodial
assays.
3.2. IC50 Values of AS, AND, and CUR. IC50s for artesunate
(AS), andrographolide (AND), and curcumin (CUR) were
found to be 0.05, 9.1, and 17.4μM, respectively. It was noted
that the compounds are particularly inhibiting the parasites
at their ring stage.
3.3. In Vitro Drug Interaction. The fraction IC50s( F I C 50)o f
the combinations made out of the three compounds was
found much below the level of their individual IC50s, as
expected. The sums of the FIC values (

FIC) are an impor-
tant parameter that detects and diﬀerentiates the classiﬁca-
tion of the drug interaction. When the sum of putative drug
fractions is 1, the combination is said to be additive; when
the sum is <1, the combination is synergistic; and when the
sum is >1, the combination is antagonistic [19]. Curcumin
(Figure 1(d)) was found to be a better combination partner
with andrographolide as compared to artesunate with sum
FIC50s in the former combination (AND+CUR) remainingJournal of Tropical Medicine 3
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Figure 1: (a) Chromatogram showing puriﬁcation of andrographolide (AND, retention time, 3.776) from crude bark extracts of Androgra-
phis paniculata. (b) Chromatogram showing the peaks for andrographolide (retention time, 3.757) in standard andrographolide. (c) Struc-
ture of andrographolide. (d) Structure of curcumin, (e) and (f) Representative isobolograms of the interactions between andrographolide
with curcumin (e) and andrographolide with artesunate (f) againstchloroquine-resistant strains (MRC-pf-303) of P. falciparum. The values
inX-andY-axesoftheisobologramsrepresent theFIC50 valuesofandrographolide-curcumin andandrographolide-artesunate, respectively,
at diﬀe r e n tc o n c e n t r a t i o nr a t i o s( 1:5 ,1:2 ,2:1 ,a n d5:1 ) .( g )In vivo eﬃcacy of andrographolide (AND), curcumin (CUR) and artesunate
(AS), tested in isolationand combinationin Plasmodium berghei ANKA-infected mice.
within 1 (0.73, 0.38, 0.43, and 0.75) in all 4 ratios (1:5, 1:2,
2:1,and5:1),respectively . This combination (AND+CUR)
atlowerratios(1:2and2:1)yieldedsynergism, whilehigher
ratios (1:5 and 5:1) exhibited additiveness as shown by
the isobologram (Figure 1(e)). Alternatively, AND+AS was
found eﬀectiveonly at lower ratios (1:2 and 2:1) with prov-
en additivity, (sum FIC50s being 0.9 and 0.8), respectively.
This combination (AND+AS) exhibited indiﬀerence with
sum FIC50s exceeding 1 (1.15 and 1.04) at higher ratios (1:5
and 5:1), respectively (Figure 1(f)).
3.4. In Vivo Antimalarial Activity of Test Compounds without
Any Toxicity. The results indicated that andrographolide
performed better anti-malarial activity when combined with4 Journal of Tropical Medicine
curcumin than artesunate. All the mice died after attaining
the parasitemia level 80% ± 4%. Control group, which died
between 13 to 15 days (maximum deaths being on 14th
day), were found to harbor 81%± 2% parasitemia compared
to the experimental groups treated with AND, AS, CUR,
AND+AS, and AND+CUR, carrying load of parasitemia,
46%, 33%, 46%, 36%, and 29%, respectively (Figure 1(f)).
All the treatment groups were kept under observation, and
the % parasitemia were monitored till the 30th day (data not
shown).
Because of the interesting in vitro anti-malarial prop-
erties, in vivo toxicity tests were carried out with mice by
intraperitonealroutesduringfourconsecutivedays.Nomor-
tality or any other abnormality was observed during the
treatment period. Treated mice were clinically healthy, and
no toxic eﬀects and weight loss were observed with the treat-
ment groups even after 96hrs. The levels of SGOT (serum
glutamic oxaloacetic transaminase) and SGPT (serum glu-
tamic pyruvate transaminase) and the blood parameters of
the experimental and control mice were found within the
normal range without any signiﬁcant variation (SGOT,
60.3 ± 3.1; SGPT, 74 ± 4.4U/mL; urea, 19.6±2.1mg/dL;
glucose, 90 ± 3.2mg/dL; creatinine, 0.77 ± 0.16mg/dL).
4.Discussion
Andrographolide is a labdane diterpene reported to have
potent anti- inﬂammatory, anticancer and anti-viral activity
[9].Assuch,theuseofantibacterials andantivirals inmalaria
prophylaxis is also well documented [20]. Identiﬁcation of
anti-plasmodial activity of this compound in view of its
eﬃcacious in vitro and in vivo performance opens up several
opportunities for further exploration of this compound as a
new anti-malarial.
During the erythrocytic life cycle, the period of activity
of andrographolide was found evidently on the ring stage of
the parasite. The point of action of this compound in the
parasite life cycle corresponds with the protein and nucleic
acid synthesis. Hence, they could be the “transcription
blockers”;more studies focusing on this particular aspect are
in progress.
The pharmacological targets of this compound and its
mechanism of action on P. falciparum are not known. How-
ever, the clue centers on the phenomenon of regulation of
a transcription factor. As per Hidalgo et al. [9], the anti-
inﬂammatory action of andrographolide includes inhibition
of the nuclear transcription factor-(kappa) B, making it a
therapeutic target for the treatment of cancer and autoim-
mune diseases. The role of NF-kappaB (NF-κB) is also
important in malaria as mentioned in a recent study [21]; P.
falciparum infected erythrocytes have shown to induce NF-
(kappa) B-regulated inﬂammatory pathways in human cere-
bral endothelium. The deciphering of anti-malarial activity
in andrographolide against the blood stage of the plasmodial
life cycle lays foundation to reevaluate its possible role in
the regulation of this important transcription factor for the
eﬀective control of malaria.
There are several reports on various drug combinations
showing theirinvitroandinvivointeractionsonmalariapar-
asites [16,22,23].Thesynergy betweenandrographolideand
curcumin is interesting in the ﬁght against the emergence of
drug resistance among parasites. Both curcumin and andro-
grapholides being from the plant sources are already doc-
umented for their antioxidant [24] and anti-inﬂammatory
properties [25], respectively. This information also gen-
erates scope to explore the possibility of modifying the
molecular structures of both the plant-derived compounds
such as andrographolide and curcumin with the objec-
tive of increasing their speciﬁc activity against plasmodial
species. The semisynthetic modiﬁcation of artemisinin to
artesunate, artemether, and DHA has already yielded com-
pounds with signiﬁcantly higher activity. The other ﬁnding
that deciphers the additiveness of andrographolide with
artesunate, the most potent artemisinin derivative makes
it important in the context that it oﬀers opportunities to
further standardize new ACT- (artemisinin-based combi-
nation therapies-) based formulae as possible antimalarial
combination.
Andrographolide exhibited high level of activity in mu-
rine model when administered either with curcumin or
artesunate by the intraperitoneal route, without any toxicity.
The substantial decrease in level of parasitemia in response
to test drug combinations compared to the control and
extended periods of life, observed with the mice is the main
ﬁnding of the present study. This may be attributed to
the observed in vitro synergism or addictiveness between
the putative drug compounds in diﬀerent combination
ratios. However, studies are in progress for eﬀective dose
determination for complete clearance of parasitemia from
infected mice using AND+CUR and AND+AS combina-
tions.
Conclusion
Although andrographolide keeps the potency of a suitable
lead candidate against malaria, further optimizations are
needed for its inclusion in the future prophylaxis as a
therapeutic agent. Relatively rapid developmentof resistance
to most of the drugs arises in response to drug pressure
[26] .I tc a na l s oh a p p e ni nt h er e c e n tf u t u r et ot h eA C T ,
w h i c hi sn o wb e i n gp r o m o t e da sag o l ds t a n d a r df o rm a l a r i a
therapy by World Health Organization. The synergistic
activity of andrographolide with curcumin could address
this issue and generate optimism for further exploration of
a new anti-malarial formula by modifying the molecular
structures in various possible ways. Of course, equally
important will be the investigative line which would study
the bioavailability of the said compounds in in vivo sys-
tem.
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